Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

Clinical trial NCT05412004 · COMPLETED

Trial details

NCT number: NCT05412004
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obstructive Sleep Apnea Obesity

Start date: 2022-06-21
Primary completion: 2024-03-12
Enrollment: 469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.